WATERTOWN, Mass., April 30, 2020 (GLOBE NEWSWIRE) — Selecta Biosciences, Inc. (NASDAQ: SELB), a clinical-stage biotechnology company focused on unlocking […]
Company Accepts Outstanding Nasdaq Delisting DeterminationPHOENIX, AZ, April 30, 2020 (GLOBE NEWSWIRE) — Taronis Technologies, Inc., (“Taronis” or “the Company”) […]